Prostate cancer decisions — 2024

The Veteran's claim for service connection for PTSD, Insomnia, and Residuals of Prostate Cancer was denied. The Veteran's appeal for an increased rating in excess of 50 percent for Generalized Anxiety Disorder is also denied.,Service connection for PTSD was not granted due to the lack of a current DSM-5 diagnosis.

The Board has remanded the claims for service connection for ischemic heart disease and prostate cancer due to a failure to establish the Veteran's presence in the Republic of Vietnam, including within 12 nautical miles of shore. The PACT Act is now applicable, and the AOJ should consider whether the Veteran was exposed to herbicide agents while aboard the USS Midway.

The Veteran's service connection claim for prostate cancer is granted due to presumed exposure to herbicide agents. However, his initial compensable rating claim for bilateral hearing loss is denied.

The Board has remanded the claims of service connection for prostate cancer, TMJ disorder, bilateral high-frequency hearing loss, and PVD. The claim for erectile dysfunction is also remanded.

The Board has granted service connection for prostate cancer, diabetes mellitus type II, and coronary artery disease on a direct basis prior to August 10, 2022 due to herbicide exposure during active service in Guam.

The Veteran's claims for prostate cancer, erectile dysfunction, coronary artery disease, and SMC for loss of use of a creative organ were granted with an effective date of May 12, 2016. The decision also addressed the overpayment issue.

The Veteran's claim for a higher initial rating for unspecified trauma and stressor-related disorder is granted. The claims for service connection for hypertension, prostate cancer, and erectile dysfunction as secondary to prostate cancer are denied. The case is remanded for further action on the retinitis pigmentosa of both eyes.

The Veteran's prostate cancer was not found to be related to his service, including exposure at Camp Lejeune. The claim for service connection is denied.

The Veteran's prostate cancer residuals, rated as a voiding dysfunction, resulted in the need for an absorbent material change 2 to 4 times per day prior to October 14, 2022. Since October 14, 2022, his condition did not result in the need for an appliance or absorbent material change more than four times per day.

The Board has granted service connection for prostate cancer due to herbicide agent exposure at Fort Drum, finding that the Veteran's current diagnosis is due to his in-service exposure and resolving all reasonable doubt in his favor.

The Board denied service connection for right hip, left knee, and right knee disorders. The Veteran's prostate cancer was also not granted service connection.

The Veteran's appeal for an increased rating for voiding dysfunction and residuals of prostate cancer has been dismissed because the Veteran withdrew his request for a hearing.

The Veteran's hypertension was found not to meet the criteria for a compensable rating, and his TDIU claim was granted due to service-connected PTSD and prostate cancer impairing his ability to secure or follow a substantially gainful occupation.

The Veteran's appeal includes multiple issues related to various disabilities, including GERD and several musculoskeletal conditions. The initial rating for GERD was denied due to the lack of symptoms meeting a higher rating criteria. Other claims are remanded as there is insufficient information regarding the Veteran's service-connected periods.

The Veteran's prostate cancer status-post prostatectomy is presumed to be related to his in-service exposure to burn pits and other toxins during service in Southwest Asia, and thus service connection is granted effective August 10, 2022.

The Board denied service connection for prostate cancer and type 2 diabetes mellitus, finding no evidence of in-service exposure to herbicide agents and no credible medical nexus between the conditions and service.,Both prostate cancer and type 2 diabetes mellitus were diagnosed many years after service, raising doubt about their relationship to military service.

The Veteran's hypertension is granted as presumptively related to herbicide agent exposure. The claims for right upper extremity, left upper extremity, and right lower extremity peripheral neuropathy are denied due to lack of current diagnoses.

The Veteran's service connection claims for adrenal cancer, chronic lymphocytic leukemia, coronary artery disease, kidney cancer, gallbladder/chronic cholecystitis, prostate cancer, and squamous cell carcinoma in situ are remanded due to the need for a TERA examination and further development of his exposure history.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no evidence of in-service exposure to herbicide agents and insufficient evidence linking the current condition to his military service.

The Veteran's claim for service connection for residuals of prostate cancer under the PACT Act is granted. The claims for PTSD, obstructive sleep apnea, hypertension, and erectile dysfunction are denied.